166.42
-2.63(-1.56%)
Currency In USD
| Previous Close | 169.05 |
| Open | 164.99 |
| Day High | 168.66 |
| Day Low | 164.23 |
| 52-Week High | 182.52 |
| 52-Week Low | 102.97 |
| Volume | 616,423 |
| Average Volume | 814,796 |
| Market Cap | 9.37B |
| PE | 8,321 |
| EPS | 0.02 |
| Moving Average 50 Days | 159.29 |
| Moving Average 200 Days | 135.94 |
| Change | -2.63 |
If you invested $1000 in Repligen Corporation (RGEN) 10 years ago, it would be worth $7,154.77 as of January 09, 2026 at a share price of $166.42. Whereas If you bought $1000 worth of Repligen Corporation (RGEN) shares 5 years ago, it would be worth $808.3 as of January 09, 2026 at a share price of $166.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
GlobeNewswire Inc.
Jan 06, 2026 12:30 PM GMT
WALTHAM, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Board has elected Dr. Martin D. Madaus as Chair of the Board, eff
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
GlobeNewswire Inc.
Dec 18, 2025 12:30 PM GMT
WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the J.P. Morgan 2026 Healthcare Conference, be
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
GlobeNewswire Inc.
Dec 16, 2025 12:30 PM GMT
WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new high-performance chromatography resins: AVIPure® H